Consequently, this study aimed to assess the prognostic value of a 22‐gene mutational profile obtained via targeted sequencing of primary breast cancer specimens from patients with ER+/ERBB2‐ EBC archived in the tissue bank under an extended follow‐up. Here, ERBB2 is linked to breast cancer.